India’s first fully indigenously developed Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has received the approval from Drug Controller General of India (DCGI). It will be utilized for active immunization against invasive disease and pneumonia caused by “Streptococcus pneumonia” among infants.
Pneumococcal Polysaccharide Conjugate Vaccine (Pneumonia vaccine) has been developed by Serum Institute of India Pvt Ltd, Pune. It is India’s first indigenously developed vaccine in the field of pneumonia. With the DCGI’s approval, Serum Institute of India has been granted permission to manufacture the vaccine domestically.
The Indian Space Research Organization (ISRO) has announced that its LVM3-M6 mission will be launched…
Rivers and freshwater areas are home to many powerful and unique animals. Some of them…
An important reform aimed at strengthening India’s banking system the Central Board of Directors of…
The Postgraduate Institute of Medical Education and Research (PGIMER) Chandigarh, has once again emerged as…
Light is all around us, and it is made up of many different colours. Each…
To strengthening rural banking in India the Ministry of Finance has unveiled a new common…